A Study of RPL554 in Patients With Cystic Fibrosis
Status:
Completed
Trial end date:
2017-11-03
Target enrollment:
Participant gender:
Summary
This study evaluates two doses of RPL554 and placebo in adult patients with cystic fibrosis.
All patients receive all three treatments in a randomised sequence.